| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.098 | 0.5 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.5 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.6 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |